Additional information
White Powder
1795133-97-9
ACI-016504
197.6-198.3°C
C44H56N4O12
832.94
Ambient
2-8°C
Antiasthmatic
Pharmaceutical Impurity Standards
1): N-[2-Hydroxy-5-[1-hydroxy-2-[methyl[[2-(4-methoxyphenyl)-1-methylethyl]amino] ethyl]phenyl]formamide Fumarate (2:1) (Formoterol Fumarate Imp.D (EP) as Fumarate salt)
N-[2-Hydroxy-5-[1-hydroxy-2-[methyl[[2-(4-methoxyphenyl)-1-methylethyl]amino] ethyl]phenyl]formamide Fumarate
Formamide, N-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]methylamino]ethyl]phenyl]-, 2-butenedioate : (Formoterol Fumarate Imp.D (EP) as Fumarate salt)





![sec-BUTYL PACLITAXEL (25 mg) ((2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-Bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (αR,βS)-α-hydroxy-β-[[(2S)-2-methyl-1-oxobutyl]amino]benzenepropanoate)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)